SCHEMBL3479772

SCHEMBL3479772

CN1CCN(c2ccc3c(c2)CN(C)CCN3c2ccccc2F)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 1/20 0.46
MAPT P10636 4/20 0.44
MAPK1 P28482 3/20 0.44
KDM4E B2RXH2 2/20 0.44
GAA P10253 2/20 0.44
PTK2B Q14289 2/20 0.44
HTT P42858 1/20 0.44
RECQL P46063 1/20 0.44
ADRA2C P18825 3/20 0.43
HTR6 P50406 2/20 0.43
DRD3 P35462 1/20 0.43
WEE1 P30291 1/20 0.41
ALDH1A1 P00352 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HRH4 Q9H3N8 1/20 0.40
KMT2A Q03164 3/20 0.40
GFER P55789 2/20 0.40
MEN1 O00255 1/20 0.40
ESR2 Q92731 1/20 0.40
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479645 0.92 HTR3A (0.41) HTR3AMAPTMAPK1KDM4EGAA
SCHEMBL3226172 0.92 SLC6A2 (0.44) HTR3AMAPTMAPK1KDM4EGAA
SCHEMBL3232992 0.90 RORC (0.45) MAPTHTR6ALDH1A1GFERTDP1
SCHEMBL3231453 0.89 HSD17B10 (0.56) MAPK1KDM4EHTTHTR6DRD3
SCHEMBL3479662 0.87 ALDH1A1 (0.50) HTR3AMAPTMAPK1KDM4EGAA
SCHEMBL3224500 0.85 SLC6A2 (0.48) HTR3AMAPTKDM4EADRA2CDRD3
SCHEMBL3479777 0.83 ADRA2C (0.51) HTR3AMAPTMAPK1KDM4EGAA
SCHEMBL3222404 0.83 MEN1 (0.49) MAPTKDM4EADRA2CDRD3ALDH1A1
SCHEMBL3479739 0.83 GAA (0.46) HTR3AMAPTMAPK1KDM4EGAA
SCHEMBL3479640 0.82 ALDH1A1 (0.50) HTR3AMAPTMAPK1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D HTR3A 30/4885MAPT 2307/4885MAPK1 2578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.